Related Content
Search Google Scholar for:
|
|
Science 19 September 1986: Vol. 233. no. 4770, pp. 1286 - 1293 DOI: 10.1126/science.3018924
|
|
Articles
Science, Vol 233, Issue 4770, 1286-1293
Copyright © 1986 by American Association for the Advancement of Science
The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating
TJ Smith,
MJ Kremer,
M Luo,
G Vriend,
E Arnold,
G Kamer,
MG Rossmann,
MA McKinlay,
GD Diana,
and
MJ Otto
WIN 51711 and WIN 52084 are structurally related, antiviral compounds that inhibit the replication of rhino (common cold) viruses and related picornaviruses. They prevent the pH-mediated uncoating of the viral RNA. The compounds consist of a 3-methylisoxazole group that inserts itself into the hydrophobic interior of the VP1 beta-barrel, a connecting seven-membered aliphatic chain, and a 4-oxazolinylphenoxy group (OP) that covers the entrance to an ion channel in the floor of the "canyon." Viral disassembly may be inhibited by preventing the collapse of the VP1 hydrophobic pocket or by blocking the flow of ions into the virus interior.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Pocket Factors Are Unlikely To Play a Major Role in the Life Cycle of Human Rhinovirus.
- U. Katpally and T. J. Smith (2007)
J. Virol.
81, 6307-6315
| Abstract »
| Full Text »
| PDF »
- Inhibition of HIV-1 Maturation via Drug Association with the Viral Gag Protein in Immature HIV-1 Particles.
- J. Zhou, L. Huang, D. L. Hachey, C. H. Chen, and C. Aiken (2005)
J. Biol. Chem.
280, 42149-42155
| Abstract »
| Full Text »
| PDF »
- Capsid structure and dynamics of a human rhinovirus probed by hydrogen exchange mass spectrometry.
- L. Wang and D. L. Smith (2005)
Protein Sci.
14, 1661-1672
| Abstract »
| Full Text »
| PDF »
- From the Cover: Dissociation of an antiviral compound from the internal pocket of human rhinovirus 14 capsid.
- Y. Li, Z. Zhou, and C. B. Post (2005)
PNAS
102, 7529-7534
| Abstract »
| Full Text »
| PDF »
- Structural and Virological Studies of the Stages of Virus Replication That Are Affected by Antirhinovirus Compounds.
- Y. Zhang, A. A. Simpson, R. M. Ledford, C. M. Bator, S. Chakravarty, G. A. Skochko, T. M. Demenczuk, A. Watanyar, D. C. Pevear, and M. G. Rossmann (2004)
J. Virol.
78, 11061-11069
| Abstract »
| Full Text »
| PDF »
- Discrimination among Rhinovirus Serotypes for a Variant ICAM-1 Receptor Molecule.
- C. Xiao, T. J. Tuthill, C. M. Bator Kelly, L. J. Challinor, P. R. Chipman, R. A. Killington, D. J. Rowlands, A. Craig, and M. G. Rossmann (2004)
J. Virol.
78, 10034-10044
| Abstract »
| Full Text »
| PDF »
- Mechanism of Action at the Molecular Level of the Antiviral Drug 3(2H)-Isoflavene against Type 2 Poliovirus.
- A. L. Salvati, A. De Dominicis, S. Tait, A. Canitano, A. Lahm, and L. Fiore (2004)
Antimicrob. Agents Chemother.
48, 2233-2243
| Abstract »
| Full Text »
| PDF »
- The dimerization domain of the HIV-1 capsid protein binds a capsid protein-derived peptide: A biophysical characterization.
- M. T. Garzon, M. C. Lidon-Moya, F. N. Barrera, A. Prieto, J. Gomez, M. G. Mateu, and J. L. Neira (2004)
Protein Sci.
13, 1512-1523
| Abstract »
| Full Text »
| PDF »
- VP1 Sequencing of All Human Rhinovirus Serotypes: Insights into Genus Phylogeny and Susceptibility to Antiviral Capsid-Binding Compounds.
- R. M. Ledford, N. R. Patel, T. M. Demenczuk, A. Watanyar, T. Herbertz, M. S. Collett, and D. C. Pevear (2004)
J. Virol.
78, 3663-3674
| Abstract »
| Full Text »
| PDF »
- Structure of Swine Vesicular Disease Virus: Mapping of Changes Occurring during Adaptation of Human Coxsackie B5 Virus To Infect Swine.
- N. Verdaguer, M. A. Jimenez-Clavero, I. Fita, and V. Ley (2003)
J. Virol.
77, 9780-9789
| Abstract »
| Full Text »
| PDF »
- A Cellular Receptor of Human Rhinovirus Type 2, the Very-Low-Density Lipoprotein Receptor, Binds to Two Neighboring Proteins of the Viral Capsid.
- E. Neumann, R. Moser, L. Snyers, D. Blaas, and E. A. Hewat (2003)
J. Virol.
77, 8504-8511
| Abstract »
| Full Text »
| PDF »
- A ligand-binding pocket in the dengue virus envelope glycoprotein.
- Y. Modis, S. Ogata, D. Clements, and S. C. Harrison (2003)
PNAS
100, 6986-6991
| Abstract »
| Full Text »
| PDF »
- Human Rhinovirus Type 16: Mutant V1210A Requires Capsid-Binding Drug for Assembly of Pentamers To Form Virions during Morphogenesis.
- W.-M. Lee and W. Wang (2003)
J. Virol.
77, 6235-6244
| Abstract »
| Full Text »
| PDF »
- Complexes of Poliovirus Serotypes with Their Common Cellular Receptor, CD155.
- Y. He, S. Mueller, P. R. Chipman, C. M. Bator, X. Peng, V. D. Bowman, S. Mukhopadhyay, E. Wimmer, R. J. Kuhn, and M. G. Rossmann (2003)
J. Virol.
77, 4827-4835
| Abstract »
| Full Text »
| PDF »
- Picornavirus uncoating.
- M S Smyth and J H Martin (2002)
Mol. Pathol.
55, 214-219
| Abstract »
| Full Text »
| PDF »
- Kinetic Analysis of the Effect of Poliovirus Receptor on Viral Uncoating: the Receptor as a Catalyst.
- S. K. Tsang, B. M. McDermott, V. R. Racaniello, and J. M. Hogle (2001)
J. Virol.
75, 4984-4989
| Abstract »
| Full Text »
- An Antiviral Compound That Blocks Structural Transitions of Poliovirus Prevents Receptor Binding at Low Temperatures.
- A. W. Dove and V. R. Racaniello (2000)
J. Virol.
74, 3929-3931
| Abstract »
| Full Text »
- Mutation of Predicted Virion Pit Residues Alters Binding of Theiler's Murine Encephalomyelitis Virus to BHK-21 Cells.
- S. Hertzler, M. Luo, and H. L. Lipton (2000)
J. Virol.
74, 1994-2004
| Abstract »
| Full Text »
- Analysis of three structurally related antiviral compounds in complex with human rhinovirus 16.
- A. T. Hadfield, G. D. Diana, and M. G. Rossmann (1999)
PNAS
96, 14730-14735
| Abstract »
| Full Text »
| PDF »
- Activity of Pleconaril against Enteroviruses.
- D. C. Pevear, T. M. Tull, M. E. Seipel, and J. M. Groarke (1999)
Antimicrob. Agents Chemother.
43, 2109-2115
| Abstract »
| Full Text »
- Antiviral agent blocks breathing of the common cold virus.
- J. K. Lewis, B. Bothner, T. J. Smith, and G. Siuzdak (1998)
PNAS
95, 6774-6778
| Abstract »
| Full Text »
| PDF »
- WIN 52035-Dependent Human Rhinovirus 16: Assembly Deficiency Caused by Mutations near the Canyon Surface.
- W. Wang, W.-M. Lee, A. G. Mosser, and R. R. Rueckert (1998)
J. Virol.
72, 1210-1218
| Abstract »
| Full Text »
| PDF »
- Structure-Based Strategies for Drug Design and Discovery.
- I. D. Kuntz (1992)
Science
257, 1078-1082
| Abstract »
| PDF »
- The three-dimensional structure of canine parvovirus and its functional implications.
- J Tsao, M. Chapman, M Agbandje, W Keller, K Smith, H Wu, M Luo, T. Smith, M. Rossmann, R. Compans, et al. (1991)
Science
251, 1456-1464
| Abstract »
| PDF »
- Molecular targets for AIDS therapy.
- H Mitsuya, R Yarchoan, and S Broder (1990)
Science
249, 1533-1544
| Abstract »
| PDF »
- Computer-aided molecular design.
- J. McCammon (1987)
Science
238, 486-491
| Abstract »
| PDF »
- New Opportunities in Synchrotron X-ray Crystallography.
- C. T. PREWITT, P. COPPENS, J. C. PHILLIPS, and L. W. FINGER (1987)
Science
238, 312-319
| Abstract »
| PDF »
- The atomic structure of Mengo virus at 3.0 A resolution.
- M Luo, G Vriend, G Kamer, I Minor, E Arnold, M. Rossmann, U Boege, D. Scraba, G. Duke, and A. Palmenberg (1987)
Science
235, 182-191
| Abstract »
| PDF »
- Viral capsid mobility: A dynamic conduit for inactivation.
- K. Broo, J. Wei, D. Marshall, F. Brown, T. J. Smith, J. E. Johnson, A. Schneemann, and G. Siuzdak (2001)
PNAS
98, 2274-2277
| Abstract »
| Full Text »
| PDF »
|
|